CDKN2A and type 2 diabetes mellitus: The remaining seven variants (IGF2BP2, CDK5, SLC30A8, CDKN2A, HHEX, TCF7L2 and FTO) evaluated in this study are from the recently identified gene regions that provide convincing evidence of their involvement in T2D in fine mapping and multiple GWA studies.